RT @EuropePMC: New from #CSO_Scotland https://t.co/TVdD1cCyJ7 Antiplatelet and anticoagulant agents for primary prevention of thrombosis in…
New from #CSO_Scotland https://t.co/TVdD1cCyJ7 Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
#Nuevarevisión de @cochranecollab: Agentes antiplaquetarios y anticoagulantes para la #prevención primaria de la #trombosis en pacientes con #AnticuerposAntifosfolipídicos – 9 estudios, 1044 participantes. https://t.co/SaBGAO82fa @CochraneVasc (En inglés,
RT @CochraneLibrary: New @cochranecollab Review: Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals…
RT @CochraneLibrary: New @cochranecollab Review: Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals…
According to the authors the overall quality of evidence is low to moderate due to unclear or high risk of bias, small number of studies and imprecise results.
RT @CochraneLibrary: New @cochranecollab Review: Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals…
RT @CochraneLibrary: New @cochranecollab Review: Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals…
New @cochranecollab Review: Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies - Nine studies involving 1044 randomised participants. https://t.co/zepmeEFGmp @CochraneVasc https://t.c
RT @CochraneVasc: New review #CochraneEvidence Antiplatelet & anticoagulant agents for primary prevention of thrombosis in individuals with…
New review #CochraneEvidence Antiplatelet & anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies #APS:no clear differences in thrombotic events in any comparison group https://t.co/E9dg7w0LrX @vascul
RT @CochraneVasc: New review #CochraneEvidence Antiplatelet & anticoagulant agents for primary prevention of thrombosis in individuals wit…
New review #CochraneEvidence Antiplatelet & anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies #APS:no clear differences in thrombotic events in any comparison group https://t.co/E9dg7w0LrX @vascu